Abstract:microRNAs (miRNAs) are a class of non-coding small RNAs that act as negative regulators of gene expression by binding to the 3'-untranslated region (3'-UTR) of target mRNAs. Tumor protein p53, a transcriptional factor, plays an important role in the progression of tumorigenesis. miR-150 was the only miRNA predicted to target 3'-UTR of p53 by TargetScan. In order to investigate the function of miR-150, p53 and relevant miRNAs in non-small cell lung cancer (NSCLC), we constructed two expression vectors of p53 (pcDNA3.1-p53 and pcDNA3.1-p53-3'-UTR) and two report vectors (pGL3-p53-3'-UTR and pGL3-p53-3'-mUTR). The activity of luciferase transfected with miR-150 mimics was lower by 30% when compared to that of the miRNA-negative control (miRNA-NC). Moreover, the p53 protein was downregulated by at least 50% when miR-150 mimics were cotransfected with pcDNA3.1-p53-3'-UTR when compared to miRNA-NC. We also determined the expression of miR-150 and p53 in NSCLC patient tissue samples. The expression of miR-150 in T2 stage tissue samples was higher than that in T1 stage tissue samples. The corresponding target gene p53 was correlated with miR-150 expression. In the present study, we further analyzed the cell cycle distribution. The cells transfected with pcDNA3.1-p53 were significantly arrested in the G1 phase when compared to the control cells. When miR-150 mimics were cotransfected with pcDNA3.1-p53-3'-UTR, the percentage of cells in the G1 phase was significantly lower by 4% when compared to miRNA-NC. To identify miRNAs that are regulated by the p53 protein, qRT-PCR was performed after pcDNA3.1-p53 transfection. miR-34a, miR-184, miR-181a and miR-148 were upregulated significantly. However, there was no distinct difference in the expression of miR-10a, miR-182 and miR-34c. Our results showed that miR-150 targets the 3'-UTR of p53, and p53 protein promotes the expression of miRNAs which affect cell cycle progression. These findings suggest that miR-150, p53 protein and relevant miRNAs are members of a regulatory network in NSCLC tumorigenesis.

Mir199a-3P Regulates P53 by Targeting CABLES1 in Mouse Cardiac C-Kit + Cells to Promote Proliferation and Inhibit Apoptosis Through a Negative Feedback Loop

MiR‐590‐3p regulates cardiomyocyte P19CL6 proliferation, apoptosis and differentiation in vitro by targeting PTPN1 via JNK/STAT/NF‐kB pathway

miRNA-204 drives cardiomyocyte proliferation via targeting Jarid2

Inactivation of Oncogenic Camp-Specific Phosphodiesterase 4D by Mir-139-5p in Response to P53 Activation

Inhibition of Mir-322-5p Protects Cardiac Myoblast Cells Against Hypoxia-Induced Apoptosis and Injury Through Regulating CIAPIN1.

Crucial Role of Mir-433 in Regulating Cardiac Fibrosis.

Mir-19B Controls Cardiac Fibroblast Proliferation and Migration.

Mir-499 Regulates Cell Proliferation And Apoptosis During Late-Stage Cardiac Differentiation Via Sox6 And Cyclin D1

Loss of Circigf1r Suppresses Cardiomyocytes Proliferation by Sponging Mir-362-5p

Epigenetic Aberrations of Mir-369-5p and DNMT3A Control Patched1 Signal Pathway in Cardiac Fibrosis

Insulin-like growth factor-1-mediated regulation of miR-193a expression promotes the migration and proliferation of c-kit-positive mouse cardiac stem cells

MiR-31a-5p Protects Myocardial Cells Against Apoptosis by Targeting Tp53.

Mir-488-3p Protects Cardiomyocytes Against Doxorubicin-Induced Cardiotoxicity by Inhibiting CyclinG1

Mir-499 Protects Cardiomyocytes from H 2O 2-Induced Apoptosis Via Its Effects on Pdcd4 and Pacs2.

Mir-150, P53 Protein And Relevant Mirnas Consist Of A Regulatory Network In Nsclc Tumorigenesis

Mir-1393 p is related to left ventricular hypertrophy and cardiomyocyte apoptosis in two-kidney one-clip hypertensive rats

Abstract 167: Mir-195-3p/-5p Decrease Cardiac Fibroblast Proliferation and the Transdifferentiation into Myofibroblasts

MiR-142 and miR-212 synergistically inhibits the proliferation and collagen formation of TGF-β1-induced cardiac fibroblasts by regulating c-Myc/TP53INP1.

Mir-125B-5p Regulates Cardiomyocyte Apoptosis in Heart Failure Model by Targeting CACNB1: a Mechanistic Study

Inhibition of miR-195-3p protects against cardiac dysfunction and fibrosis after myocardial infarction

MiR-199a-3p Inhibition Facilitates Cardiomyocyte Differentiation of Embryonic Stem Cell Through Promotion of MEF2C.